Table 1.
Drug | Oral dosing
|
Intravenous | Hydroxyapatite binding affinity ranking | FPPS potency ranking | ||
---|---|---|---|---|---|---|
Daily | Weekly | Monthly | ||||
Ibandronate | 2.5 mg | 20 mg | 150 mg | 3 mg every 3 months | Third | Third |
Risedronate | 5 mg | 35 mg | 150 mg | Fourth | Second | |
Alendronate | 5 and 10 mg | 35 and 70 mg | Second | Fourth | ||
Zoledronic acid | 5 mg annually | First | First |
Abbreviation: FPPS, farnesyl pyrophosphate synthase.